Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-29
2011-03-29
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S279000
Reexamination Certificate
active
07915264
ABSTRACT:
The invention provides compounds of formula (I) wherein R1, R2, R3, R4, and R5are as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as pharmaceuticals.
REFERENCES:
patent: 2749344 (1956-06-01), Hitchings et al.
patent: 5958930 (1999-09-01), Gangjee
patent: WO 95/18616 (1995-07-01), None
patent: WO 98/02162 (1998-01-01), None
Hcaplus77:88424.
Hcaplus 138:70679.
Chemical Abstract No. 133:261086 & M. Oguchi et al., J.Med.Chem., No. 43 (16), pp. 3052-3066 (2000).
Chemical Abstract No. 132:78525 & J.Y.Liu et al., Youji, Hauxue, No. 19(6), pp. 582-586 (1999).
Wall, Mark et al., Journal of Medicinal Chemistry, “A Multisubstrate Adduct Inhibitor of AICAR Transformylase”, vol. 42, No. 18, , pp. 3421-3424 (1999).
McIntyre P. et al., British Journal of Pharmacology, “Pharmacological differences between the human and rat vanilloid receptor 1 (VRI)”, No. 321, pp. 1084-1094 (2001).
Bae et al,Tetrahedron Lett, vol. 41, No. 31, pp. 5899-5902 (2000).
Dave et al.,Indian J Pharma Sci, vol. 48, No. 3, pp. 75-77 (1986).
Fox et al.,JACS, vol. 122, pp. 1360-1370 (2000), and supporting information.
Korte et al.,Chem Ber, vol. 85, pp. 1012-1019 (1952).
Martin et al.,Tetrahedron, vol. 50, No. 7, pp. 2255-2264 (1994).
Matyus et al.,Leibigs Ann Chem, vol. 10, pp. 1653-1661 (1984).
PCT search report for PCT/EP 02/03332, Sep. 23, 2002.
Petrow et al.,J Chem Soc, pp. 1389-1392 (1948).
Robins et al.,J Am Chem Soc, vol. 77, pp. 2256-2259 (1955).
Robins et al.,J Am Chem Soc, Am Chem Soc, vol. 80, No. 13, pp. 3449-3457 (1958).
Roh et al.,Synth Comm, vol. 30, No. 1, pp. 81-86 (2000).
Trattner et al.,J Org Chem, Am Chem Soc, vol. 29, pp. 2674-2677 (1964).
Troschuetz et al.,Arch Pharm, vol. 311, No. 5, pp. 406-414 (1978).
Tschitschibabin et al.,Chem Ber, vol. 60, p. 775 (1927).
Culshaw Andrew James
Gull Peter
Hallett Allan
Kim Hong-Yong
Liu Yugang
Aulakh Charanjit S
Novartis AG
LandOfFree
Fused pyridine derivatives for use as vanilloid receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused pyridine derivatives for use as vanilloid receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused pyridine derivatives for use as vanilloid receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2657505